Delta Technology Holdings Limited (DELT) At $1.62 Forms Bottom; Kindred Healthcare Has 1.32 Sentiment

Kindred Healthcare, Inc. provides healthcare services in the United States. The company has market cap of $836.92 million. It operates in six divisions: Hospitals, Home Health Services, Hospice Services, Kindred Hospital Rehabilitation Services, RehabCare, and Nursing Centers. It currently has negative earnings. The firm provides long-term acute care services to post-intensive care and medically complex patients, including the critically ill, suffering from multiple organ system failures, most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.

Delta Technology Holdings Limited (DELT) formed multiple bottom with $1.47 target or 9.00% below today’s $1.62 share price. Delta Technology Holdings Limited (DELT) has $19.21M valuation. The stock decreased 5.26% or $0.09 during the last trading session, reaching $1.62. About 106,727 shares traded. Delta Technology Holdings Limited (NASDAQ:DELT) has risen 165.00% since January 21, 2017 and is uptrending. It has outperformed by 148.30% the S&P500.

Phoenix Investment Adviser Llc holds 1.1% of its portfolio in Kindred Healthcare, Inc. for 207,500 shares. Smith Graham & Co. Investment Advisors Lp owns 1.24 million shares or 0.88% of their US portfolio. Moreover, Campbell & Co Investment Adviser Llc has 0.18% invested in the company for 33,482 shares. The New York-based Glenview Capital Management Llc has invested 0.17% in the stock. Altrinsic Global Advisors Llc, a Connecticut-based fund reported 637,000 shares.

Analysts await Kindred Healthcare, Inc. (NYSE:KND) to report earnings on February, 26. They expect $0.21 EPS, up 162.50% or $0.13 from last year’s $0.08 per share. KND’s profit will be $19.21M for 10.89 P/E if the $0.21 EPS becomes a reality. After $-0.11 actual EPS reported by Kindred Healthcare, Inc. for the previous quarter, Wall Street now forecasts -290.91% EPS growth.

Ratings analysis reveals 0 of Kindred Healthcare’s analysts are positive. Out of 3 Wall Street analysts rating Kindred Healthcare, 0 give it “Buy”, 1 “Sell” rating, while 2 recommend “Hold”. The lowest target is $5.0 while the high is $9.0. The stock’s average target of $7 is -23.50% below today’s ($9.15) share price. KND was included in 3 notes of analysts from November 8, 2016. Stifel Nicolaus downgraded the shares of KND in report on Tuesday, November 8 to “Sell” rating. The firm earned “Neutral” rating on Tuesday, November 8 by Mizuho. RBC Capital Markets downgraded Kindred Healthcare, Inc. (NYSE:KND) rating on Thursday, November 10. RBC Capital Markets has “Sector Perform” rating and $9.0 target.